Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Canadian guideline for Parkinson disease.
Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M, Suchowersky O, Rajput A, Lafontaine AL, Mestre T, Appel-Cresswell S, Kalia SK, Schoffer K, Zurowski M, Postuma RB, Udow S, Fox S, Barbeau P, Hutton B. Grimes D, et al. CMAJ. 2019 Sep 9;191(36):E989-E1004. doi: 10.1503/cmaj.181504. CMAJ. 2019. PMID: 31501181 Free PMC article. No abstract available.
Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.
Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE. Postuma RB, et al. Neurology. 2017 Oct 24;89(17):1795-1803. doi: 10.1212/WNL.0000000000004568. Epub 2017 Sep 27. Neurology. 2017. PMID: 28954882 Free PMC article. Clinical Trial.
Gender and funding success.
Appel-Cresswell S, Blanchet PJ, Wysocki J, Postuma RB. Appel-Cresswell S, et al. Lancet. 2019 Jun 1;393(10187):2195-2196. doi: 10.1016/S0140-6736(19)31107-9. Lancet. 2019. PMID: 31162073 No abstract available.
Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease.
Sacheli MA, Neva JL, Lakhani B, Murray DK, Vafai N, Shahinfard E, English C, McCormick S, Dinelle K, Neilson N, McKenzie J, Schulzer M, McKenzie DC, Appel-Cresswell S, McKeown MJ, Boyd LA, Sossi V, Stoessl AJ. Sacheli MA, et al. Mov Disord. 2019 Dec;34(12):1891-1900. doi: 10.1002/mds.27865. Epub 2019 Oct 4. Mov Disord. 2019. PMID: 31584222 Clinical Trial.
Imaging of compensatory mechanisms in Parkinson's disease.
Appel-Cresswell S, de la Fuente-Fernandez R, Galley S, McKeown MJ. Appel-Cresswell S, et al. Curr Opin Neurol. 2010 Aug;23(4):407-12. doi: 10.1097/WCO.0b013e32833b6019. Curr Opin Neurol. 2010. PMID: 20610991 Review.
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, Weir D, Thompson C, Szu-Tu C, Trinh J, Aasly JO, Rajput A, Rajput AH, Jon Stoessl A, Farrer MJ. Appel-Cresswell S, et al. Mov Disord. 2013 Jun;28(6):811-3. doi: 10.1002/mds.25421. Epub 2013 Mar 1. Mov Disord. 2013. PMID: 23457019
Functional neuroimaging in Parkinson's disease.
de la Fuente-Fernández R, Appel-Cresswell S, Doudet DJ, Sossi V. de la Fuente-Fernández R, et al. Expert Opin Med Diagn. 2011 Mar;5(2):109-20. doi: 10.1517/17530059.2011.554820. Epub 2011 Feb 1. Expert Opin Med Diagn. 2011. PMID: 23480585
Gender differences in Parkinson's disease depression.
Perrin AJ, Nosova E, Co K, Book A, Iu O, Silva V, Thompson C, McKeown MJ, Stoessl AJ, Farrer MJ, Appel-Cresswell S. Perrin AJ, et al. Parkinsonism Relat Disord. 2017 Mar;36:93-97. doi: 10.1016/j.parkreldis.2016.12.026. Epub 2016 Dec 29. Parkinsonism Relat Disord. 2017. PMID: 28089265
44 results